Headquarters
Spain
Every company in the roster headquartered in Spain.
Research
Compare company financial metrics
Research adds sourced market cap, cash, runway and annualized R&D figures with metric-specific sorting.
Views
5 of 5 companies
| Company | Pipeline | Most advanced | Next readout |
|---|---|---|---|
 GrifolsGRF · BME | 2 assets: 1 Ph 3, 1 Ph 2 | Human hepatitis B Immunoglobulin (Hepatect®CP/Zutectra®)Phase 3 · Chronic Hepatitis B | None on record |
 Araclon Biotech (Grifols)Private | 1 asset: 1 Ph 2 | ABvac40Phase 2 · Alzheimer's DiseasePartial signal | None on record |
 Aromics TherapeuticsPrivate | 1 asset: 1 Ph 1 | AROG4-01Phase 1 · Non-Small Cell Lung Cancer | None on record |
 Gyala TherapeuticsPrivate | 1 asset: 1 Ph 2 | CART84Phase 1/2 · Acute Myeloid Leukemia | 31 May 2029CART84 · Phase 1/2 |
 Oryzon Genomics, S.A.ORY · BME | 1 asset: 1 Ph 2 | IadademstatPhase 2 · Acute Myeloid LeukemiaWeak signal | None on record |
Next readout: the earliest estimated primary completion of a trial the company or a partner on the asset runs (ClinicalTrials.gov).